WallStreetZenWallStreetZen

NASDAQ: IMVT
Immunovant Inc Stock Ownership - Who owns Immunovant?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immunovant Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Atul PandeDirector2026-07-241,500$39.80
$59.70kSell
Atul PandeDirector2026-07-241,500$8.43
$12.65kBuy
Tiago GiraoCFO2026-07-236,798$38.69
$263.01kSell
Jay S. StoutCTO2026-07-232,857$38.69
$110.54kSell
Tuyl Christopher VanChief Legal Officer2026-07-0863$39.99
$2.52kSell
Jay S. StoutChief Technology Officer2026-07-081,399$39.53
$55.30kSell
Jay S. StoutChief Technology Officer2026-07-0877$39.99
$3.08kSell
Melanie GloriaChief Operating Officer2026-07-081,930$39.53
$76.29kSell
Jay S. StoutChief Technology Officer2026-07-081,906$39.53
$75.34kSell
Jay S. StoutChief Technology Officer2026-07-08105$39.99
$4.20kSell

1 of 8

IMVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMVT insiders and whales buy or sell their stock.

IMVT Shareholders

What type of owners hold Immunovant Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roivant Sciences Ltd55.19%113,317,007$4.47BInsider
Fmr LLC8.25%16,947,888$669.10MInstitution
Deep Track Capital LP5.61%11,526,971$455.08MInstitution
Blackrock Inc3.20%6,574,497$259.56MInstitution
Baker Bros Advisors LP2.66%5,457,881$215.48MInstitution
State Street Corp2.21%4,537,929$179.16MInstitution
Tcg Crossover Management LLC2.17%4,457,988$176.00MInstitution
Morgan Stanley1.89%3,876,877$153.06MInstitution
Vanguard Portfolio Management LLC1.80%3,704,905$146.27MInstitution
Vanguard Capital Management LLC1.76%3,620,050$142.92MInstitution

1 of 3

IMVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMVT48.12%51.88%Net BuyingNet Selling
TGTX58.59%41.41%Net Selling
PCVX88.95%11.05%Net SellingNet Selling
IBRX16.99%7.30%Net BuyingNet Selling
LQDA47.10%52.90%Net SellingNet Selling
View Top Biotech Stocks

Immunovant Stock Ownership FAQ

Who owns Immunovant?

Immunovant (NASDAQ: IMVT) is owned by 53.87% institutional shareholders, 58.09% Immunovant insiders, and 0.00% retail investors. Roivant Sciences Ltd is the largest individual Immunovant shareholder, owning 113.32M shares representing 55.19% of the company. Roivant Sciences Ltd's Immunovant shares are currently valued at $4.38B.

If you're new to stock investing, here's how to buy Immunovant stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.